Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

3 doses, then 1 each year: why Pfizer, not AstraZeneca, is the best bet for the long haul

By Nathan Bartlett, Associate Professor, School of Biomedical Sciences and Pharmacy, University of Newcastle
Share this article
Last week, the chief executive of Pfizer said anyone who receives its COVID-19 vaccine will probably need to have a third dose within 6-12 months after being fully immunised, and then likely one dose every year going forward.

We’ll need these because it’s likely that, for many of us, immunity will begin to wane within that time frame. The vaccine will also need to be tweaked to cover new coronavirus variants as they emerge.

The advantage…


Read complete article

© The Conversation -


Follow us on ...
Facebook Twitter